Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 115 Pages
Report ld: 5558826
Request Sample
Customized Report
Hemostatic Forceps Market Size(US$)

CAGR 2026-2032
4.3%
Market Size,2032
USD 90.6
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
The global Hemostatic Forceps market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Hemostatic Forceps sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Hemostatic Forceps manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Hemostatic Forceps product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hemostatic Forceps value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemostatic Forceps Product Scope
1.2 Hemostatic Forceps by Type
1.2.1 Global Hemostatic Forceps Sales by Type (2021, 2025 & 2032)
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Hemostatic Forceps by Application
1.3.1 Global Hemostatic Forceps Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Global Hemostatic Forceps Market Estimates and Forecasts (2021-2032)
1.4.1 Global Hemostatic Forceps Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Hemostatic Forceps Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Hemostatic Forceps Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Hemostatic Forceps Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Hemostatic Forceps Historical Market Scenario by Region (2021-2026)
2.2.1 Global Hemostatic Forceps Sales Market Share by Region (2021-2026)
2.2.2 Global Hemostatic Forceps Revenue Market Share by Region (2021-2026)
2.3 Global Hemostatic Forceps Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Hemostatic Forceps Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Hemostatic Forceps Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Hemostatic Forceps Market Size and Prospects (2021-2032)
2.4.2 Europe Hemostatic Forceps Market Size and Prospects (2021-2032)
2.4.3 China Hemostatic Forceps Market Size and Prospects (2021-2032)
2.4.4 Japan Hemostatic Forceps Market Size and Prospects (2021-2032)
2.4.5 Pakistan Hemostatic Forceps Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Hemostatic Forceps Historical Market Review by Type (2021-2026)
3.1.1 Global Hemostatic Forceps Sales by Type (2021-2026)
3.1.2 Global Hemostatic Forceps Revenue by Type (2021-2026)
3.1.3 Global Hemostatic Forceps Average Price by Type (2021-2026)
3.2 Global Hemostatic Forceps Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Hemostatic Forceps Sales Forecast by Type (2027-2032)
3.2.2 Global Hemostatic Forceps Revenue Forecast by Type (2027-2032)
3.2.3 Global Hemostatic Forceps Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Hemostatic Forceps
4 Global Market Size by Application
4.1 Global Hemostatic Forceps Historical Market Review by Application (2021-2026)
4.1.1 Global Hemostatic Forceps Sales by Application (2021-2026)
4.1.2 Global Hemostatic Forceps Revenue by Application (2021-2026)
4.1.3 Global Hemostatic Forceps Average Price by Application (2021-2026)
4.2 Global Hemostatic Forceps Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Hemostatic Forceps Sales Forecast by Application (2027-2032)
4.2.2 Global Hemostatic Forceps Revenue Forecast by Application (2027-2032)
4.2.3 Global Hemostatic Forceps Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Hemostatic Forceps Applications
5 Competition Landscape by Players
5.1 Global Hemostatic Forceps Sales by Player (2021-2026)
5.2 Global Top Hemostatic Forceps Players by Revenue (2021-2026)
5.3 Global Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Hemostatic Forceps revenue as of 2025
5.4 Global Hemostatic Forceps Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Hemostatic Forceps, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hemostatic Forceps, Product Type & Application
5.7 Global Key Manufacturers of Hemostatic Forceps, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Hemostatic Forceps Sales by Company
6.1.1.1 North America Hemostatic Forceps Sales by Company (2021-2026)
6.1.1.2 North America Hemostatic Forceps Revenue by Company (2021-2026)
6.1.2 North America Hemostatic Forceps Sales Breakdown by Type (2021-2026)
6.1.3 North America Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6.1.4 North America Hemostatic Forceps Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Hemostatic Forceps Sales by Company
6.2.1.1 Europe Hemostatic Forceps Sales by Company (2021-2026)
6.2.1.2 Europe Hemostatic Forceps Revenue by Company (2021-2026)
6.2.2 Europe Hemostatic Forceps Sales Breakdown by Type (2021-2026)
6.2.3 Europe Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6.2.4 Europe Hemostatic Forceps Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Hemostatic Forceps Sales by Company
6.3.1.1 China Hemostatic Forceps Sales by Company (2021-2026)
6.3.1.2 China Hemostatic Forceps Revenue by Company (2021-2026)
6.3.2 China Hemostatic Forceps Sales Breakdown by Type (2021-2026)
6.3.3 China Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6.3.4 China Hemostatic Forceps Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Hemostatic Forceps Sales by Company
6.4.1.1 Japan Hemostatic Forceps Sales by Company (2021-2026)
6.4.1.2 Japan Hemostatic Forceps Revenue by Company (2021-2026)
6.4.2 Japan Hemostatic Forceps Sales Breakdown by Type (2021-2026)
6.4.3 Japan Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6.4.4 Japan Hemostatic Forceps Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Pakistan Market: Players, Segments, Downstream and Major Customers
6.5.1 Pakistan Hemostatic Forceps Sales by Company
6.5.1.1 Pakistan Hemostatic Forceps Sales by Company (2021-2026)
6.5.1.2 Pakistan Hemostatic Forceps Revenue by Company (2021-2026)
6.5.2 Pakistan Hemostatic Forceps Sales Breakdown by Type (2021-2026)
6.5.3 Pakistan Hemostatic Forceps Sales Breakdown by Application (2021-2026)
6.5.4 Pakistan Hemostatic Forceps Major Customers
6.5.5 Pakistan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Medline
7.1.1 Medline Company Information
7.1.2 Medline Business Overview
7.1.3 Medline Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Medline Hemostatic Forceps Products Offered
7.1.5 Medline Recent Development
7.2 B. Braun
7.2.1 B. Braun Company Information
7.2.2 B. Braun Business Overview
7.2.3 B. Braun Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.2.4 B. Braun Hemostatic Forceps Products Offered
7.2.5 B. Braun Recent Development
7.3 CareFusion
7.3.1 CareFusion Company Information
7.3.2 CareFusion Business Overview
7.3.3 CareFusion Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.3.4 CareFusion Hemostatic Forceps Products Offered
7.3.5 CareFusion Recent Development
7.4 Asa Dental
7.4.1 Asa Dental Company Information
7.4.2 Asa Dental Business Overview
7.4.3 Asa Dental Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Asa Dental Hemostatic Forceps Products Offered
7.4.5 Asa Dental Recent Development
7.5 Sklar
7.5.1 Sklar Company Information
7.5.2 Sklar Business Overview
7.5.3 Sklar Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Sklar Hemostatic Forceps Products Offered
7.5.5 Sklar Recent Development
7.6 Scanlan International
7.6.1 Scanlan International Company Information
7.6.2 Scanlan International Business Overview
7.6.3 Scanlan International Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Scanlan International Hemostatic Forceps Products Offered
7.6.5 Scanlan International Recent Development
7.7 Shanghai Medical Instruments
7.7.1 Shanghai Medical Instruments Company Information
7.7.2 Shanghai Medical Instruments Business Overview
7.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Shanghai Medical Instruments Hemostatic Forceps Products Offered
7.7.5 Shanghai Medical Instruments Recent Development
7.8 Lawton
7.8.1 Lawton Company Information
7.8.2 Lawton Business Overview
7.8.3 Lawton Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Lawton Hemostatic Forceps Products Offered
7.8.5 Lawton Recent Development
7.9 Hu-Friedy
7.9.1 Hu-Friedy Company Information
7.9.2 Hu-Friedy Business Overview
7.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Hu-Friedy Hemostatic Forceps Products Offered
7.9.5 Hu-Friedy Recent Development
7.10 Xinhua Surgical
7.10.1 Xinhua Surgical Company Information
7.10.2 Xinhua Surgical Business Overview
7.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Xinhua Surgical Hemostatic Forceps Products Offered
7.10.5 Xinhua Surgical Recent Development
7.11 Towne Brothers
7.11.1 Towne Brothers Company Information
7.11.2 Towne Brothers Business Overview
7.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Towne Brothers Hemostatic Forceps Products Offered
7.11.5 Towne Brothers Recent Development
7.12 Teleflex Medical
7.12.1 Teleflex Medical Company Information
7.12.2 Teleflex Medical Business Overview
7.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Teleflex Medical Hemostatic Forceps Products Offered
7.12.5 Teleflex Medical Recent Development
7.13 Delacroix Chevalier
7.13.1 Delacroix Chevalier Company Information
7.13.2 Delacroix Chevalier Business Overview
7.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Delacroix Chevalier Hemostatic Forceps Products Offered
7.13.5 Delacroix Chevalier Recent Development
7.14 YDM
7.14.1 YDM Company Information
7.14.2 YDM Business Overview
7.14.3 YDM Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.14.4 YDM Hemostatic Forceps Products Offered
7.14.5 YDM Recent Development
7.15 M A Corporation
7.15.1 M A Corporation Company Information
7.15.2 M A Corporation Business Overview
7.15.3 M A Corporation Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.15.4 M A Corporation Hemostatic Forceps Products Offered
7.15.5 M A Corporation Recent Development
7.16 MedGyn Products
7.16.1 MedGyn Products Company Information
7.16.2 MedGyn Products Business Overview
7.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.16.4 MedGyn Products Hemostatic Forceps Products Offered
7.16.5 MedGyn Products Recent Development
7.17 Inami
7.17.1 Inami Company Information
7.17.2 Inami Business Overview
7.17.3 Inami Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Inami Hemostatic Forceps Products Offered
7.17.5 Inami Recent Development
7.18 Ted Pella
7.18.1 Ted Pella Company Information
7.18.2 Ted Pella Business Overview
7.18.3 Ted Pella Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Ted Pella Hemostatic Forceps Products Offered
7.18.5 Ted Pella Recent Development
7.19 Medicon eG
7.19.1 Medicon eG Company Information
7.19.2 Medicon eG Business Overview
7.19.3 Medicon eG Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.19.4 Medicon eG Hemostatic Forceps Products Offered
7.19.5 Medicon eG Recent Development
7.20 J & J Instruments
7.20.1 J & J Instruments Company Information
7.20.2 J & J Instruments Business Overview
7.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.20.4 J & J Instruments Hemostatic Forceps Products Offered
7.20.5 J & J Instruments Recent Development
7.21 American Diagnostic
7.21.1 American Diagnostic Company Information
7.21.2 American Diagnostic Business Overview
7.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
7.21.4 American Diagnostic Hemostatic Forceps Products Offered
7.21.5 American Diagnostic Recent Development
8 Hemostatic Forceps Manufacturing Cost Analysis
8.1 Hemostatic Forceps Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hemostatic Forceps
8.4 Hemostatic Forceps Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Hemostatic Forceps Distributors List
9.3 Hemostatic Forceps Customers
10 Hemostatic Forceps Market Dynamics
10.1 Hemostatic Forceps Industry Trends
10.2 Hemostatic Forceps Market Drivers
10.3 Hemostatic Forceps Market Challenges
10.4 Hemostatic Forceps Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 2900.00
(Single User License)
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 163
USD 3950.00
(Single User License)
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 200
USD 4900.00
(Single User License)
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 181
USD 5900.00
(Single User License)
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 111
USD 4250.00
(Single User License)
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 159
USD 3950.00
(Single User License)
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-16
Pages: 117
USD 2900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-17
Pages: 207
USD 5600.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-07
Pages: 129
USD 4900.00
(Single User License)
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 163
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 200
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 181
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 111
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 159
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-16
Pages: 117
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-17
Pages: 207
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-16
Pages: 186
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-07
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now